Presented at The 2024 ACMG Annual Clinical Genetics Meeting by Genomenon Founder and Chief Scientific Officer, Mark Kiel, MD, PhD.
We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.